Bendroflumethiazide - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for bendroflumethiazide and what is the scope of patent protection?
Bendroflumethiazide
is the generic ingredient in five branded drugs marketed by Apothecon, King Pharms Llc, Impax Labs, and Natco Pharma, and is included in four NDAs. Additional information is available in the individual branded drug profile pages.There are four drug master file entries for bendroflumethiazide.
Summary for bendroflumethiazide
| US Patents: | 0 |
| Tradenames: | 5 |
| Applicants: | 4 |
| NDAs: | 4 |
| Drug Master File Entries: | 4 |
| Raw Ingredient (Bulk) Api Vendors: | 76 |
| Clinical Trials: | 4 |
| Patent Applications: | 6,270 |
| DailyMed Link: | bendroflumethiazide at DailyMed |
Recent Clinical Trials for bendroflumethiazide
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Yale University | Phase 1 |
| Mylan Pharmaceuticals | Phase 1 |
| Steno Diabetes Center Copenhagen | Phase 4 |
Medical Subject Heading (MeSH) Categories for bendroflumethiazide
Anatomical Therapeutic Chemical (ATC) Classes for bendroflumethiazide
US Patents and Regulatory Information for bendroflumethiazide
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Impax Labs | NADOLOL AND BENDROFLUMETHIAZIDE | bendroflumethiazide; nadolol | TABLET;ORAL | 077833-001 | Mar 30, 2007 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Apothecon | NATURETIN-2.5 | bendroflumethiazide | TABLET;ORAL | 012164-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Apothecon | NATURETIN-5 | bendroflumethiazide | TABLET;ORAL | 012164-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Natco Pharma | NADOLOL AND BENDROFLUMETHIAZIDE | bendroflumethiazide; nadolol | TABLET;ORAL | 078688-001 | Feb 15, 2008 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Apothecon | NATURETIN-10 | bendroflumethiazide | TABLET;ORAL | 012164-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| King Pharms Llc | CORZIDE | bendroflumethiazide; nadolol | TABLET;ORAL | 018647-001 | May 25, 1983 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Impax Labs | NADOLOL AND BENDROFLUMETHIAZIDE | bendroflumethiazide; nadolol | TABLET;ORAL | 077833-002 | Mar 30, 2007 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
